Dr. Dayna Long, Medical Director and Researcher, UCSF Benioff Children’s Hospital, Oakland Center for Child and Community Health, discusses her involvement in the All In For Kids virtual series that took place in December 2020, and how research has shown that persistent childhood adversity – abuse, neglect, violence, racism, and other forms of trauma – can lead to higher rates of illness (cancer, stroke, Alzheimer’s, etc.) later in life. COVID-19 has exacerbated the trauma, isolation, and stress kids are experiencing and is disproportionately affecting Black, Latinx, Indigenous, and other communities of color.
Dr. Irene Ghobrial, MD, clinical investigator and senior physician at Dana-Farber Cancer Institute and Professor of Medicine at Harvard School of Medicine, discusses the partnering of the Dana-Farber Cancer Institute with Quest Diagnostics to identify the prevalence of COVID-19 in individuals with a precursor to multiple myeloma through the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing). She talks about how COVID 19 affects myeloma patients and various racial groups, and how the IMPACT study will play a role in the diagnostic recovery for this population.
Dr. Jackie Walters, 2-time breast cancer survivor, OB/GYN, TV personality (Married To Medicine), bestselling author (The Queen of V), and podcast host (Power of V) discusses cervical cancer and the importance of potentially life-saving screenings for women – including those for cervical cancer – and why women should make sure to schedule an annual wellness exam in 2021.
Dr. Jeremy Horst, DDS, Director, Clinical Innovation for DentaQuest discusses dental health inequities and outlines some solutions to close the gap, ways to improve access to care in communities in need, and advancing policies to help make this possible.
Dr. Jeannine Hoang, M.D., owner and operator of four United Dermatology Associates locations throughout North Texas discusses her mission to provide exceptional healthcare to patients of various ages, offering services in cosmetic dermatology, medical dermatology and surgical dermatology. She says that she’s “intrigued by the field of preventive medicine and anti-aging and actively learning about proactive approaches to maintain health and function through healthy lifestyle habits.” She is unable to treat the skin effectively without looking at the overall health of the person.
Dr. Kenyon Godwin, D.C., owner and operator of two Active Family Wellness Centers in Arlington, TX, discusses his approach to healing with an effective lifestyle modification program utilizing Functional Medicine. The program incorporates the best of wellness: Chiropractic, Nutrition, Detox, Comprehensive labs, Supplements, Massage, Fitness, Mentorship and Meditation/Prayer. His goal is to make Arlington the healthiest city in Texas.
Dr. Caroline Loew, President and CEO of Glympse Bio, a clinical stage biotechnology company, discusses the company’s development of tunable biosensors capable of noninvasive disease monitoring in NASH, other fibrotic diseases, and Non-Small Cell Lung Cancer. They serve as a repeatable alternative to biopsy, allowing patients to be monitored more frequently without the need for a surgical procedure.
Dr. Preetesh Jain, Assistant Professor, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, discusses new CALQUENCE® (acalabrutinib) data presented at ASH 2020 demonstrating long-term efficacy and tolerability at three years for patients with mantle cell lymphoma (MCL).
Returning guest, Dr. David Spetzler, President and Chief Scientific Officer and Dr. Jim Abraham, Senior Vice President and Chief Data Officer at Caris Life Sciences discuss positive results from validation studies of MI FOLFOXai™, Caris Life Sciences’ artificial intelligence (AI)-based predictor that gauges a metastatic colorectal cancer (mCRC) patient’s likelihood of benefiting from the sequence of two first-line, standard of care treatments. These results were published in “Clinical Cancer Research” a publication of the “American Association for Cancer Research”.
Returned guest, Kent Thoelke, Chief Scientific Officer and Executive Vice President at PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contract research provider discusses decentralized and virtual clinical trials and the impact on the future of pharmaceuticals.